Can high-grade cervical lesions be managed in a single clinic visit?
Lisa C Richardson* and Vicki B Benard
Correspondence *Division of Cancer Prevention and Control, National Center of Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, Mailstop K-55, Atlanta, GA 30341, USA
Email lfr8@cdc.gov
This article has no abstract so we have provided the first paragraph of the full text.
Since the introduction of the Pap test five decades ago cervical cancer mortality has decreased by over 75%, yet in 2002 in the US 12,085 new cases of cervical cancer were diagnosed, and 3,952 deaths from this disease were reported.1 Low-income, African American, and Latina women experience higher cervical cancer incidence and mortality, partly because of their poor compliance with screening and follow-up. The primary factors affecting follow-up after abnormal screening test results include lack of health insurance, limited transportation, lack of childcare, and lack of access to health-care facilities,2 and fatalistic attitudes and beliefs about cancer. The more severe the findings of an abnormal Pap test (the most serious being HGSIL and carcinoma in situ) the more likely follow-up is to occur.3 Follow-up of abnormal Pap test results remains a challenge.
Full text of this article is available with one of the following:
- Personal subscription Purchase your own personal subscription to this journal. Already a subscriber? Please log in for immediate access.
- 7 day single article pass for US$18 In order to purchase this article you must be a registered user. Please register or log in.
- Site licence Learn more about institutional site licences
Current Subscribers
Please log in to access the full text article using the login box at the top of the page.
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.